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AbstrAct
Some ethnic minorities with type 1 diabetes (T1D) have 
worse glycemic control (higher glycated hemoglobin 
(HbA1
c
)) and increased risk for vascular complications. 
There is limited evidence on the impact of ethnicity on 
early glycemic control when most patients experience 
transient remission postdiagnosis. We examined 
associations between ethnicity and longitudinal HbA1
c
 
trajectories during the first 6 months postdiagnosis in a 
multiethnic cohort in East London.
Research design and methods Data on 443 (50% 
female) children <19 years of age, with T1D and attending 
one of three clinics in East London between January 
2005 and December 2015 were included. Linear mixed-
effects modeling was used to assess ethnic differences 
in longitudinal HbA1
c
 trajectories during the first 6 months 
postdiagnosis (1,028 HbA1
c
 data points), adjusting for 
sex, age at diagnosis, socioeconomic status and pH 
at diagnosis. Growth curve modeling was used to plot 
discrete HbA1
c
 trajectories by ethnicity.
Results Longitudinal modeling revealed that all ethnic 
minorities had higher mean HbA1
c
 at diagnosis compared 
with White children and highest in Bangladeshi (9.7 mmol/
mol, 95% CI 5.1 to 14.3), Asian-Other (5.8 mmol/mol, 
95% CI 2.2 to 9.3) and Somali (5.2 mmol/mol, 95% CI 0.1 
to 10.2) children, and these differences persisted over the 
6-month period after diagnosis. During the first month, 
HbA1
c
 decreased on average by 19.6 mmol/mol (95% CI 
−21 to −18) for all children. Population averaged HbA1
c
 
decreased between diagnosis and 4 months, followed by 
a gradual increase in HbA1
c
 levels (mean difference of 
−30 mmol/mol between diagnosis and 6 months).
Conclusions Ethnic minorities present with higher HbA1
c
 
at diagnosis, with the largest mean differences observed 
in Bangladeshi, Asian-Other and Somali children. These 
higher levels (indicating poorer glycemic control) track into 
the first 6 months postdiagnosis.
IntroductIon
Inequalities in pediatric type 1 diabetes 
outcomes are well recognized.1 Children and 
young people (CYP) of lower socioeconomic 
status (SES) and ethnic minorities tend to 
have poorer glycemic control and increased 
risk for acute life-threatening complications 
(diabetic ketoacidosis and hypoglycemia) and 
chronic vascular complications in later life.2–4 
In a recent study using national data on >95% 
of CYP with type 1 diabetes in England and 
Wales, we found that all ethnic minorities 
had poorer glycemic control (higher blood 
glycated hemoglobin (HbA1c) concentra-
tions) compared with White CYP.5 Lower SES 
was associated with poor glycemic control in 
all ethnic groups, but being poor and ethnic 
minority had significantly worse impact on 
glycemic control than being poor and White.
Studies show that young patients from 
lower SES and ethnic minority backgrounds 
receive a later diagnosis of type 1 diabetes and 
present with significantly worse symptoms at 
diagnosis (greater severity of diabetic ketoac-
idosis and higher HbA1c levels).
6 7 A greater 
level of metabolic derangement at diagnosis 
may reflect factors such as poorer/late access 
to medical care,6 8 cultural and/or biological 
differences between ethnic groups and also 
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significance of this study
What is already known about this subject?
 ► Ethnic minority children are at greater risk for poorer 
glycemic control. Almost all patients with type  1 
diabetes go through a period of transient remission 
immediately after diagnosis when the need for 
exogenous insulin declines.
What are the new findings?
 ► All ethnic minorities had significantly higher glycated 
hemoglobin (HbA1
c
) at diagnosis compared with 
White children, and differences were reported for the 
first time in Bangladeshi and Somali children resident 
in the UK. The ethnic differences in glycemic control 
persisted during the period of transient remission 
and up to 6 months postdiagnosis.
How might these results change the focus of 
research or clinical practice?
 ► Interventions early on, at the time of diagnosis and 
during the first few months are needed to reduce 
ethnic  differences in glycemic control and are 
especially important as poor early glycemic control 
is likely to track into later life.
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a lower level of residual pancreatic beta cell function.9 
There have been reports on associations between clinical 
presentation at diagnosis and subsequent early glycemic 
control.10 Therefore, if ethnic minorities present with 
worse clinical factors at diagnosis, one could hypoth-
esize that the stabilization of glycemic control during 
the period of transient remission (‘honeymoon phase’) 
experienced by most newly diagnosed patients with type 
1 diabetes could also differ by ethnic background.11 
However, this has not been comprehensively investigated 
in a multiethnic population in the UK. This is especially 
important to study as early glycemic control during the 
first year postdiagnosis is linked to subsequent future 
control which may track into adulthood.12
To identify groups of CYP with poor glycemic control 
based on clinical factors at presentation, we investigated 
ethnic differences in stabilization of glycemic control 
during the first 6 months postdiagnosis in a multiethnic 
population attending diabetes clinics in East London. We 
also analyzed ethnic differences in ketoacidosis severity 
at diagnosis (pH levels) and if this affected subsequent 
glycemic control during the first 6 months. Identification 
of patients with initial and subsequent poor glycemic 
control could help in devising targeted policies to help 
these CYP have better outcomes in the future.
Methods
design, setting and data source
We undertook a longitudinal cohort study of newly 
diagnosed patients with type 1 diabetes using data from 
three pediatric diabetes clinics that are part of the same 
Healthcare Trust (Barts Health NHS Trust) located 
in East London, UK. The three clinics largely capture 
patients living in surrounding areas of East London, 
where up to 56% of the local population belongs to an 
ethnic minority, with around 50% of South Asian origin 
(primarily of Bangladeshi origin) and 40% of Black 
origin (primarily of Somali origin).
The study was restricted to children <19 years of age 
who received a diagnosis of type 1 diabetes between 1 
January 2005 and 31 December 2015 and attended any 
one of the three clinics during the same period. Exten-
sive clinical and sociodemographic data were collected 
prospectively, both at the time of diagnosis and during 
routine clinic visits. As per recommendations from 
the National Institute of Health and Care Excellence 
(NICE), a child with type 1 diabetes is offered an inte-
grated package of care by a multidisciplinary team at a 
pediatric diabetes clinic four times per year. The team 
consists of pediatric endocrinologists/diabetologists, 
diabetes specialist nurses, dieticians, psychologists and 
interpreters. HbA1c levels are recorded at each visit. All 
demographical and clinical parameters are systemati-
cally measured and electronically documented across all 
three clinics enabling comparison. Out of 596 children 
diagnosed with type 1 diabetes during the study period, 
571 (96%) children had data on sex, age at diagnosis, 
duration of diabetes, ethnicity and SES and were eligible 
to be included in the analysis.
Primary outcome, exposures and covariates
The outcome of interest was glycemic control measured 
by HbA1c levels. HbA1c was measured at each visit using 
the point of care Siemens/Bayer DCA 2000+ Analyzer. 
HbA1c values recorded as percentages were converted 
to mmol/mol using the formula: (HbA1c value in 
%−2.15)×10.929.
The main exposures of interest were ethnicity and 
SES. Participants (or their parents) were asked to 
self-identify their ethnicity when they visited a clinic and 
we used the first recorded entries for ethnicity at the 
time of diagnosis. They were given the option to choose 
1 of 15 categories or the option to decline identifying 
their ethnicity. For this study, the 15 ethnic categories 
were collapsed into six broad groups: White, mixed 
ethnicity (any mixed ethnicity combination), Black, 
African-Somali, Bangladeshi and Asian-Other (any Asian 
origin excluding Bangladeshi) which reflects the ethnic 
distribution of the study area in East London. The latter 
group included CYP mostly of Indian or Pakistani origin 
and a much smaller proportion originating from other 
Asian countries. The pH value (blood capillary samples) 
measured closest to initial presentation was used in the 
analysis.
SES was derived from postcode of residence using 
indices of multiple deprivation (IMD) 2010 for England. 
The IMD is a small geographical area measure of depriva-
tion. It is multidimensional and scores are derived from a 
weighted combination of several indicators across seven 
distinct measures of deprivation including: income, 
employment, education skills and training, health, 
barriers to housing and services, living environment and 
crime.13 It captures the ‘relative’ deprivation experienced 
by an individual living in an area. IMD scores are calcu-
lated at the level of lower-layer super output areas, with 
each area comprising 1500 individuals on average. IMD 
rank scores were grouped into quartiles for the analysis, 
with the first and fourth quartiles corresponding to the 
most and least deprived, respectively.
Other covariates adjusted for in the analysis include: 
sex, age at diagnosis calculated by subtracting date of 
diagnosis from date of birth, age at clinic visit calculated 
by subtracting date of clinic visit from date of birth, 
duration of diabetes calculated in months by subtracting 
the date at first visit in the audit year from the date of 
diagnosis of type 1 diabetes, which of the three Pedi-
atric Diabetes clinics the child attended and pH levels 
recorded at diagnosis—used as an indicator of diabetic 
ketoacidosis severity at presentation, measured in a 
subgroup of patients.
statistical analysis
Baseline characteristics were compared across all ethnic 
groups. Categorical variables were compared as frequen-
cies using χ2 or Fisher’s Exact test. Mean differences in 
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baseline continuous variables by ethnicity were analyzed 
using simple linear regression.
Stabilization of glycemic control during the first 
6 months postdiagnosis was assessed using linear mixed-ef-
fects models (ie, a random intercept and random slope 
model), which allow comparison of population average 
HbA1c levels and change over time for the different ethnic 
categories while controlling for potential covariates. We 
approximated time trends using a quadratic model for 
time since diagnosis as this provided a better statistical fit 
than a linear model. Ethnicity, SES, age at diagnosis, sex 
and diabetes clinic were entered as time-invariant predic-
tors. We constructed a series of models using the ‘mixed’ 
commands in Stata V.14 (StataCorp, College Station, 
Texas, USA). The first model (Model 1) was an unadjusted 
growth model using the quadratic function of time since 
diagnosis (disease duration in months) as the time meta-
meter. Subsequent models were additionally adjusted for 
our hypothesized predictors: sex and age at diagnosis 
in years (Model 2), ethnicity (Model 3), SES (Model 4) 
and which of the three diabetes clinic the child attended 
(Model 5). We tested for a potential interaction between 
ethnicity and duration to assess whether HbA1c trajec-
tories differed by ethnic group. We estimated all model 
parameters by maximum likelihood. We used general-
ized likelihood ratio statistics, −2 log-likelihood (−2LL), 
Aikake information criterion (AIC) and sample-adjusted 
Bayesian information criterion (BIC) to compare model 
fit between subsequent nested models and Wald statistics 
to test hypotheses about model parameters. We plotted 
quadratic growth curves at the group level (ie, ethnicity) 
to visualize model fit. Analyses were run in Stata V.14. In 
addition, we ran Models 3 and 5 above in a subgroup of 
patients with data on pH levels at diagnosis to assess any 
change to the observed ethnicity–HbA1c associations.
results
Of the 571 subjects eligible to be included, 89 were 
excluded as they did not have any recorded data during 
the first 6 months postdiagnosis. Additionally, 39 had 
missing data on HbA1c during the first 6 months post-
diagnosis leaving 443 (78% of the eligible population) 
children with 1,028 measurements of HbA1c during 
the first 6 months, and data on all covariates who were 
included in the analysis. The mean number of HbA1c 
measurements per child during the first 6 months was 2.3 
(range 1–7). Forty-one per cent presented with diabetic 
ketoacidosis at diagnosis (defined as pH levels <7.3, 
table 1).
characteristics of the study population at baseline and 
6 months postdiagnosis
Fifty per cent of the study population were female. Mean 
HbA1c (ie, the mean of all HbA1c measurements in the 
first month postdiagnosis) at diagnosis was 93.7 mmol/
mol (table 1). All ethnic groups had relatively high 
HbA1c levels at diagnosis with the highest mean levels 
observed in Bangladeshi children (99.9 mmol/mol (SD 
24.1), table 1). Mean deprivation score and the propor-
tion of subjects in the lowest SES quartile (ie, the most 
deprived) differed significantly by ethnic group, with 
the African-Somali, mixed ethnicity and Black groups 
having the lowest mean deprivation scores and largest 
proportions of CYP in the most deprived SES quar-
tile (table 1). There were no significant differences in 
HbA1c at diagnosis by SES quartiles. We observed no 
significant differences in gender, age at diagnosis and 
pH levels by ethnicity. HbA1c decreased by an average 
of 32.4 mmol/mol during the first 6 months postdiag-
nosis.
longitudinal modeling of hbA1c trajectories
Table 2 shows the regression parameters from longitu-
dinal modeling. We detected a significant difference 
in HbA1c when comparing ethnic minority children to 
White children. All ethnic minority groups had higher 
mean HbA1c levels at diagnosis compared with the White 
group. However, differences were statistically significant 
only in the Bangladeshi (8.8 mmol/mol, 95% CI 4.3 to 
13.3) and Asian-other (5.8 mmol/mol, 95% CI 2.3 to 
9.4, table 2) groups which exhibited the largest mean 
differences in HbA1c levels at diagnosis compared with 
White children. Adjustment for SES slightly enlarged 
the estimates for all ethnic groups, and the estimate for 
the African-Somali group reached statistical significance 
(5.1 mmol/mol, 95% CI 0.1 to 10.1, table 2). However, 
SES, age at diagnosis and gender were not significantly 
associated with HbA1c levels at diagnosis. We also 
observed a significant difference in mean HbA1c at diag-
nosis by diabetes clinic.
All ethnic groups experienced an initial decrease in 
HbA1c levels during the first 4 months postdiagnosis 
followed by a slight gradual increase between months 4 
and 6, with a statistically significant quadratic term in all 
models (figure 1, table 2). HbA1c levels decreased by an 
average 19.6 mmol/mol during the first month after diag-
nosis for the entire group. Likelihood ratio tests showed 
that each subsequent model had a statistically better fit 
than the preceding model with fewer covariates. Model 
5 with all covariates had the best fit (−2LL=8635 and 
AIC=8673, table 2). In the final Model 5 with all covari-
ates, 76% of the variation in HbA1c was due to individual 
differences (intraclass coefficient (ICC)=0.76, table 2).
The model testing for an interaction between ethnicity 
and duration was not statistically significant, indicating 
no evidence of a difference by ethnicity in HbA1c trajec-
tories over time (data not shown).
longitudinal modeling for change in hbA1c with ph at 
diagnosis
Longitudinal models on HbA1c trajectories adjusted for 
pH at diagnosis were restricted to a smaller sample of 338 
children with 764 HbA1c data points (average 2.3 HbA1c 
data points per subject, range 1–6) as pH at diagnosis was 
not documented in all cases.
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Table 2 Mixed-effects models for change in glycaemic control (HbA1
c
) during the first 6 months postdiagnosis in children 
with type 1 diabetes and attending paediatric diabetes clinics in East London
Covariates
Model1: growth 
model
(Mean difference 
in HbA1
c
, mmol/
mol, (95% CI))
Model 2: plus age 
at diagnosis
(Mean difference 
in HbA1
c
, mmol/
mol, (95% CI))
Model 3: plus 
ethnicity
(Mean difference in 
HbA1
c
, mmol/mol, 
(95% CI))
Model 4: plus 
socioeconomic 
status
(Mean difference in 
HbA1
c
, mmol/mol, 
(95% CI))
Model 5: plus 
pediatric diabetes 
clinic
(Mean difference 
in HbA1
c
, mmol/
mol, (95% CI))
Fixed effects
Constant/intercept 95.1 (92.4, 97.7) 97. 9 (92.5, 103.4) 93.5 (87.8, 99.3) 91.1 (84.9, 97.2) 90.4 (84.3, 96.5)
Duration
   Linear −19.6 (−21.1, 
−18.1)
−19.6 
(−21.1, −18.1)
−19.6 (−21.1, −18.1) −19.6 (−21.1, −18.1) −19.6 (−21.2, −18.1)
  Quadratic 2.4 (2.2, 2.7) 2.4 (2.2, 2.7) 2.4 (2.2, 2.7) 2.4 (2.2, 2.7) 2.4 (2.2, 2.7)
Sex
   Male Ref Ref Ref Ref
  Female −2.5 (−5.2, 0.1) −1.9 (−4.6, 0.7) −1.9 (−4.5, 0.7) −1.9 (−4.5, 0.7)
Age at diagnosis 0.1 (−0.2, 0.4) 0.1 (−0.2, 0.4) 0.1 (−0.2, 0.4) 0.1 (−0.3, 0.3)
Ethnicity
  White Ref Ref Ref
  Mixed ethnicity 4.1 (−0.9, 9.1) 4.6 (−0.4, 9.7) 3.9 (−1.0, 8.9)
  Black 3.3 (−0.9, 7.4) 3.7 (−0.5, 8.0) 4.0 (−0.1, 8.1)
  African-Somali 4.1 (−0.8, 9.1) 5.1 (0.1, 10.1) 4.5 (−0.5, 9.4)
  Bangladeshi 8.8 (4.3, 13.3) 9.3 (4.7, 14.0) 9.4 (4.8, 13.9)
  Asian-Other 5.8 (2.3, 9.4) 5.7 (2.2, 9.3) 3.9 (0.2, 7.6)
Socioeconomic status
  Quartile 1 
(poorest)
Ref Ref
  Quartile 2 3.2 (−0.3, 6.7) 2.6 (−0.8, 6.1)
  Quartile 3 3.9 (0.2, 7.6) 2.5 (−1.1, 6.3)
  Quartile 4 
(richest)
2.5 (−1.5, 6.5) 2.7 (−1.3, 6.7)
Pediatric diabetes clinic
  Clinic 1 Ref
  Clinic 2 1.7 (−2.1, 5.4)
  Clinic 3 6.1 (2.8, 9.3)
  Interclass 
correlation
0.77 0.77 0.76 0.76 0.76
Goodness of fit
  Aikake 
information 
criterion (AIC)
8690.614 8690.926 8682.079 8683.001 8673.485
  Bayesian 
information 
criterion (BIC)
8725.161 8735.345 8751.175 8766.902 8767.257
  −2 Log-likelihood 8676 8672 8654 8648 8635
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All ethnic minorities had higher mean HbA1c at diag-
nosis compared with White children as observed in 
models comprising the entire study sample (n=443), 
described above. However, estimates for the mixed and 
Black groups previously not significant were observed 
to be statistically significantly different from the White 
group. pH at diagnosis was inversely associated with HbA1c 
at diagnosis. For every one unit increase in pH levels, 
HbA1c decreased by an adjusted average of −15.7 mmol/
mol (95% CI −25.1 to −6.3, table 3). Adjusting for pH 
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Figure 1 Predicted glycemic control (glycated hemoglobin or (HbA1
c
) trajectories during the first 6 months postdiagnosis 
by ethnicity. Trajectories are estimated for a sample group with a mean age of diagnosis=9 years and indices of multiple 
deprivation=quartile 3.
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at diagnosis had no impact on the previously observed 
ethnicity–HbA1c associations (table 2).
dIscussIon
Our aim was to use longitudinal modeling to determine 
whether glycaemic control (HbA1c trajectories) differed 
by ethnicity during the first 6 months after diagnosis. As 
expected, we observed a general and rapid improvement 
in HbA1c levels for the entire study sample that reached a 
nadir around 4 months postdiagnosis. This was followed 
by a slight gradual increase in HbA1c levels between 4 
and 6 months postdiagnosis. We found that all ethnic 
minority children presented with poorer HbA1c at diag-
nosis compared with White children and the magnitude 
of this difference did not change over the study period—
the children that started behind remained behind in 
terms of glycemic control. An additional aim was to 
assess the effect of pH (a marker of disease severity at 
diagnosis) on glycemic control during the first 6 months 
after diagnosis. We found that while pH at diagnosis was 
negatively associated with HbA1c during the first month 
postdiagnosis, it did not affect the subsequent observed 
ethnicity–HbA1c trajectories.
comparisons with the literature
Few studies and none from the UK have investigated early 
glycemic control (control during the first year after diag-
nosis) using longitudinal data from diagnosis onwards. 
Most did not investigate the impact of ethnicity on early 
glycemic control, did not use advanced methods to 
analyze longitudinal data (such as mixed effects models) 
or had longer follow-up periods without focusing on the 
transient remission (‘honeymoon phase’) period as in 
this study. Our finding of initial very high HbA1c levels 
at diagnosis, followed by a steep decline, is reported in 
other studies with comparable study populations (age at 
diagnosis and proportion of female subjects). However, 
those studies that reported HbA1c levels at diagnosis and 
during the first year postdiagnosis (including data points 
at 6 months postdiagnosis) did not investigate trends in 
glycemic control and were restricted to study populations 
of White ethnicity limiting comparisons.10 14–16 Chase et 
al found a steep decline in HbA1c levels at 2–4 months 
followed by a gradual increase similar to our findings.17 
Studies that analyzed data using longitudinal modeling 
with a focus on ethnic differences in metabolic control 
had a much longer follow-up and thus did not report 
exclusively on the first 6 months postdiagnosis when most 
patients undergo transient remission.18 19 Initial high 
HbA1c levels at diagnosis and lower levels at 6 months 
reported elsewhere are similar to that observed in our 
study.
There have been conflicting reports on the associ-
ation of age at diagnosis and gender with HbA1c levels 
at diagnosis and during follow-up. Some studies report 
that females and older children have higher HbA1c levels 
at diagnosis and during follow-up, whereas others show 
an interaction between gender and age at diagnosis on 
subsequent HbA1c levels during the first year postdiag-
nosis.14 16 19 We observed no association between gender 
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Table 3 Mixed-effects  models for change in glycaemic control (HbA1
c
) during the first 6 months postdiagnosis adjusted for 
pH levels at diagnosis, in children with type 1 diabetes
Covariates
Model
1: adjusted for sex, age at diagnosis, 
pH at diagnosis and ethnicity
 (Mean difference in HbA1
c
, mmol/
mol, (95% CI))
Model 2: additionally adjusted 
for SES 
and clinic attended
 (Mean difference in HbA1
c
, 
mmol/mol, (95% CI))
Fixed effects
Constant/intercept 202.1 (134.2, 270.9) 203.7 (136.4, 271.1)
Duration
   Linear −20.6 (−22.5,–18.8) −20.8 (−22.6,–18.9)
  Quadratic 2.5 (2.3, 2.8) 2.6 (2.3, 2.8)
Sex 
  Male Ref Ref
  Female −0.5 (−3.5, 2.5) −0.4 (−3.3, 2.6)
Age at diagnosis 0.1 (−0.2, 0.5) 0.1 (−0.3, 0.4)
pH at diagnosis −15.2 (−24.7, −5.7) −15.7 (−25.1, −6.3)
Ethnicity
  White Ref Ref
  Mixed ethnicity 7.1 (1.7, 12.6) 6.5 (1.1, 11.9)
  Black 4.2 (0.2, 8.8) 4.6 (0.9, 9.1)
  African-Somali 4.7 (−0.9, 10.3) 5.2 (−0.4, 10.9)
  Bangladeshi 10.1 (4.9, 15.3) 10.6 (5.4, 15.7)
  Asian-Other 7.5 (3.4, 11.5) 5.3 (1.8, 9.4)
Socioeconomic status
  Quartile 1 (poorest)
  Quartile 2 2.2 (−1.7, 6.1)
  Quartile 3 1.9 (−2.1, 5.9)
  Quartile 4 (richest) 2.7 (−1.9, 7.3)
Pediatric diabetes clinic
  Clinic 1 Ref
  Clinic 2 1.9 (−2.5, 6.3)
  Clinic 3 6.1 (2.4, 9.6)
Goodness of fit
  Aikake information criterion (AIC) 6434.644 6430.969
  Bayesian information criterion (BIC) 6504.184 6523.688
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and age at diagnosis with initial and subsequent HbA1c 
levels.
strengths and limitations
Our methods allowed for the inclusion of a large number 
of longitudinal data points. The study sample was drawn 
from East London where the majority (67%) belonged 
to an ethnic minority. This enabled us to study for the 
first time, pediatric glycemic control in specific ethnic 
minority groups such as the Bangladeshi and Somali 
groups. Such vulnerable groups often get overlooked 
as they are analyzed in combination with other ethnic 
groups masking potential underlying differences. 
Ethnicity was self-identified which is considered to be the 
‘gold standard’ in studies on ethnicity and health.20
Our study also has certain limitations. The study sample 
was drawn from three pediatric diabetes clinics which 
operate together as a network since 2012 and results 
may not be generalizable to the rest of the country. One 
cannot exclude the possibility of residual confounding 
due to other factors known to impact on glycemic control 
at diagnosis and during early follow-up which may interact 
with ethnicity including family structure, family history 
of diabetes, pubertal status and incidence of severe 
hypoglycemia and diabetic ketoacidosis. Our finding of 
no association between SES and metabolic control at 
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diagnosis was unexpected. This could be explained by 
the fact that a significant proportion of the study sample 
was highly deprived (reflecting the neighborhood from 
which the sample was drawn) leading to low variability 
in SES. Black and mixed ethnic children have increased 
risk for poorer metabolic control.5 However, the statis-
tically non-significant estimates for both groups could 
be due to low statistical power. We were unable to calcu-
late the proportion of subjects undergoing remission at 
different time points by known methods as we lacked 
the information needed (insulin dose-adjusted HbA1c 
or total daily insulin dose/kg body weight/day). Insulin 
pump therapy is known to substantially improve glycemic 
control, but we were unable to control for treatment type 
as it was missing for a significant proportion of subjects.21 
However, we are aware that only a smaller proportion 
of subjects attending these three clinics were on insulin 
pump therapy which was introduced towards to second 
half of the study period (verbal communication) and we 
do not expect adjustment for treatment type to change 
our observed results. We plan to analyze the role of treat-
ment type in future studies on this cohort.
Several factors may explain the observed ethnic differ-
ences in metabolic control at diagnosis and during 
early follow-up including physiological (greater loss of 
insulin-producing beta cells in some ethnic groups and 
greater disease severity at diagnosis) and psychosocial 
(later presentation at diagnosis, attitudes towards under-
standing disease symptoms and seeking care at later 
stages) factors. Studies indicate that younger children 
often present with greater acidosis, experience a more 
rapid loss of insulin-producing beta cells and worse symp-
toms at diagnosis.13 However, we found no differences 
in age at diagnosis by ethnicity that could explain the 
observed differences in HbA1c at diagnosis.
Our outcomes are timely, given the long-term data 
from the Diabetes Control and Complications Trial/
Epidemiology of Diabetes Interventions and Complica-
tions (DCCT/EDIC) recently reported by Orchard and 
colleagues.22 During 30 years of follow-up, fewer cardio-
vascular disease events occurred in the former intensive 
treatment group subjects compared with the former 
conventional treatment group subjects. The lower HbA1c 
levels during the DCCT/EDIC, achieved through inten-
sive insulin therapy, statistically account for all of the 
observed treatment effect on cardiovascular disease 
risk. While similar long-term data are required for child-
hood-onset type 1 diabetes, the DCCT/EDIC outcomes 
indicate that achieving very early target HbA1c has 
important benefits in later life. The mechanisms for the 
ethnic differences observed in our study require further 
investigation.
conclusIons
Ethnic minority children with type 1 diabetes presented 
with higher mean HbA1c levels at diagnosis compared 
with White children. These differences in HbA1c by 
ethnicity were sustained throughout the study period 
including the ‘honeymoon’ phase when all groups 
experienced a steep decline in HbA1c levels. Our study 
highlights the importance for formulating interven-
tions early on, at the time of diagnosis and during the 
first few months to ensure that differences in glycemic 
control are reduced. This is especially important as 
people with poor early glycemic control are more likely 
to have poor control later in life.
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